Antares Pharma, Inc. (ATRS)

[H2R]

Hi Hyperopia,

Not sure if you meant Teva was in the competition or was competing against ATRS.

They are ATRS' partner for the EpiPen:

EWING, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that the U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries, Ltd.’s (“Teva”) epinephrine auto injector drug-device combination product indicated for emergency treatment of severe allergic reactions including those that are life threatening (anaphylaxis) in adults and certain pediatric patients. Our partner Teva filed an Abbreviated New Drug Application (ANDA) seeking FDA approval of the product as a generic substitute of Mylan’s branded product EpiPen®.

I believe only ADMP has something similar and is the only generic competition (and of course there is Mylan, however unfavorable the market is with Mylan).

Let me know if that's what you meant. I think I must have misunderstood your post.

Cheers!